Cell therapy saving lives of immunocompromised patients скачать в хорошем качестве

Cell therapy saving lives of immunocompromised patients

A powerful immunotherapy that targets out-of-control viral infections has saved the lives of dozens of critically-ill immunocompromised Australians who received the treatment on compassionate grounds. The therapy, developed by QIMR Berghofer’s Professor Rajiv Khanna and his team, is being supplied under the Therapeutic Goods Administration’s (TGA) Special Access Scheme, which allows patients to access unapproved therapeutic goods as a last resort for treatment. The Queensland research team collaborates with leading clinicians around Australia to supply the cellular immunotherapy. An analysis of their long-term experience over 15 years has been published in the journal Nature Communications.